The rising interest in GLP-1 agonists for diabetes has led to a debate about formats: transdermal systems versus pills . Typically, GLP-1 therapies were only available in oral form, but the introduction https://zaynsrqa882130.bluxeblog.com/73332390/glp-1-transdermal-delivery-systems-vs-oral-medications-which-right-for-you